| PERIOD ENDING | 11-Sep-09 | 19-Jun-09 | 27-Mar-09 | 31-Dec-08 | | Total Revenue | 903,000 | 1,054,000 | 882,000 | 1,647,000 | | Cost of Revenue | 757,000 | 797,000 | 692,000 | 1,492,000 | | | Gross Profit | 146,000 | 257,000 | 190,000 | 155,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 19,000 | 17,000 | 15,000 | (255,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 125,000 | 175,000 | 178,000 | 194,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,000 | 65,000 | (3,000) | 216,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,000 | 8,000 | 2,000 | 8,000 | | Earnings Before Interest And Taxes | 13,000 | 42,000 | (4,000) | 209,000 | | Interest Expense | 95,000 | 82,000 | 87,000 | 101,000 | | Income Before Tax | (82,000) | (40,000) | (91,000) | 108,000 | | Income Tax Expense | (25,000) | 10,000 | (14,000) | (14,000) | | Minority Interest | (2,000) | 1,000 | 1,000 | (2,000) | | | | Net Income From Continuing Ops | (59,000) | (49,000) | (76,000) | 122,000 | | | Non-recurring Events | | Discontinued Operations | (1,000) | (19,000) | 17,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (60,000) | (68,000) | (59,000) | 122,000 | | Preferred Stock And Other Adjustments | 3,000 | (2,000) | (2,000) | (3,000) | | | Net Income Applicable To Common Shares | ($57,000) | ($70,000) | ($61,000) | $119,000 |
|
0.31% Nasdaq 
0.05%
Income Statement
